Director Srinivas Akkaraju sold $1.7M of Syros Pharmaceuticals, Inc.

Sold$1,718,568

$11.11Price

154,700Shares

−10%Stake

What SYRS did after the filing

Prices for SYRS after this filing aren't in yet.

Traded Tue, Jun 23. Filed Thu, Jun 25, 4:38 PM ET, after the close. Not investment advice.